• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ENDOLOGIX AFX; BIFURCATED STENT GRAFT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ENDOLOGIX AFX; BIFURCATED STENT GRAFT Back to Search Results
Model Number BA28-90/I20-30
Device Problems Failure To Adhere Or Bond (1031); Collapse (1099); Detachment Of Device Component (1104); Leak/Splash (1354); Stretched (1601)
Patient Problem Failure of Implant (1924)
Event Date 09/28/2015
Event Type  Injury  
Manufacturer Narrative
At the completion of the clinical evaluation, based on the information received, the clinical evaluation refuted the reported type 2 endoleak.However, a type 3a endoleak with complete component separation was confirmed through patient imaging.No procedure related issue, user related issue, anatomy related issue, or contributing cautionary including off-label product use conditions could be determined due to lack of information surrounding the event.The remodeling of the system as the devices separated likely caused a stent graft collapse of the main body.Currently, there have been no reports of further negative patient sequelae; there has been no evidence of a repair procedure.The event devices remain implanted in the patient and were not available for further evaluation.The review of the manufacturing lot confirmed all devices met specifications prior to release.A root cause investigation was carried out for all afx complaints having an identified failure mode of a type 3a endoleak.The root causes have been identified as; patient anatomy including large aneurysms, aneurysm sac angulation, significant aortic neck angulation and lack of thrombus; patient conditions including disease progression or anatomical changes post implant; off label product use including patient anatomy, overlap length, oversizing between components, and placement of the devices within the anatomy of the patient.Endologix implemented the following corrective actions to reduce the type 3a endoleak events; sizing guidance and instructions were updated in the ifu and released on 06/17/2015, field training was completed by 08/03/2015.Since the corrective actions were implemented the type 3a events have been reduced significantly and are well within the acceptable range per our risk assessment.No additional investigations of this reported complaint are planned, endologix will continue to monitor this complaint and similar complaints in the event further investigation is needed.
 
Event Description
The patient was initially implanted with a bifurcated stent and a suprarenal aortic extension.It was reported the patient was diagnosed with a type 2 endoleak that was not treated.Through clinical evaluation of this reported event it was discovered the patient had a type 3a endoleak with complete component separation.There have been no reports of the patient having a secondary procedure.The patient condition remains unknown.To date there have been no additional adverse events reported to endologix for this patient.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
AFX
Type of Device
BIFURCATED STENT GRAFT
Manufacturer (Section D)
ENDOLOGIX
2 musick
irvine CA 92618
Manufacturer Contact
michelle caulfield
2 musick
irvine, CA 92618
9495984606
MDR Report Key6843887
MDR Text Key84934947
Report Number2031527-2017-00449
Device Sequence Number1
Product Code MIH
Combination Product (y/n)N
Reporter Country CodeGM
PMA/PMN Number
P040002
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Reporter Occupation Physician
Type of Report Initial
Report Date 12/16/2015
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date09/30/2014
Device Model NumberBA28-90/I20-30
Device Lot Number1101192-027
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? No
Initial Date Manufacturer Received 12/16/2015
Initial Date FDA Received09/05/2017
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured10/29/2013
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Other;
Patient Age80 YR
Patient Weight80
-
-